189 related articles for article (PubMed ID: 29390565)
1. Lymphoepithelioma-like hepatocellular carcinoma: A case report and brief review of literature.
Wang JK; Jin YW; Hu HJ; Regmi P; Ma WJ; Yang Q; Liu F; Ran CD; Su F; Zheng EL; Li FY
Medicine (Baltimore); 2017 Dec; 96(51):e9416. PubMed ID: 29390565
[TBL] [Abstract][Full Text] [Related]
2. Lymphoepithelioma-like Hepatocellular Carcinoma: a Case Report and Review of Literature.
Sweed D; Sultan MM; Mosbeh A; Fayed YA; Abdelsameea E; Ehsan NA; Abdel-Rahman MH; Waked I
J Gastrointest Cancer; 2023 Mar; 54(1):275-281. PubMed ID: 34813031
[TBL] [Abstract][Full Text] [Related]
3. Lymphoepithelioma-like hepatocellular carcinoma: an uncommon variant of hepatocellular carcinoma with favorable outcome.
Chan AW; Tong JH; Pan Y; Chan SL; Wong GL; Wong VW; Lai PB; To KF
Am J Surg Pathol; 2015 Mar; 39(3):304-12. PubMed ID: 25675010
[TBL] [Abstract][Full Text] [Related]
4. Synchronous hepatocellular carcinoma and lymphoepithelioma-like carcinoma arising from 2 different sites of the liver: A case report.
Shih EJ; Chau IY; Yeh YC; Chau GY
Medicine (Baltimore); 2018 Oct; 97(40):e12548. PubMed ID: 30290612
[TBL] [Abstract][Full Text] [Related]
5. Lymphoepithelioma-like hepatocellular carcinoma: Case report and review of the literature.
Cacciato Insilla A; Faviana P; Pollina LE; De Simone P; Coletti L; Filipponi F; Campani D
World J Gastroenterol; 2015 Sep; 21(36):10468-74. PubMed ID: 26420974
[TBL] [Abstract][Full Text] [Related]
6. Lymphoepithelioma-like hepatocellular carcinoma: a case report with emphasis on the cytological features.
Miyasaka C; Ishida M; Ito H; Kaibori M; Uemura Y; Tsuta K
Int J Clin Exp Pathol; 2017; 10(7):7893-7897. PubMed ID: 31966638
[TBL] [Abstract][Full Text] [Related]
7. Lymphoepitelioma-like hepatocellular carcinoma: a case report and a review of the literature.
Nemolato S; Fanni D; Naccarato AG; Ravarino A; Bevilacqua G; Faa G
World J Gastroenterol; 2008 Aug; 14(29):4694-6. PubMed ID: 18698686
[TBL] [Abstract][Full Text] [Related]
8. [Significance of arginase-1, glypican-3, hepatocyte paraffin antigen 1 and alpha-fetoprotein in diagnosis and differential diagnosis of liver tumors].
Li J; Wei L
Zhonghua Bing Li Xue Za Zhi; 2014 Apr; 43(4):246-50. PubMed ID: 24915815
[TBL] [Abstract][Full Text] [Related]
9. Lessons from rare tumors: hepatic lymphoepithelioma-like carcinomas.
Solinas A; Calvisi DF
World J Gastroenterol; 2015 Mar; 21(12):3472-9. PubMed ID: 25834311
[TBL] [Abstract][Full Text] [Related]
10. Differences in surgical outcomes between hepatitis B- and hepatitis C-related hepatocellular carcinoma: a retrospective analysis of a single North American center.
Franssen B; Alshebeeb K; Tabrizian P; Marti J; Pierobon ES; Lubezky N; Roayaie S; Florman S; Schwartz ME
Ann Surg; 2014 Oct; 260(4):650-6; discussion 656-8. PubMed ID: 25203882
[TBL] [Abstract][Full Text] [Related]
11. Single-center experience in the diagnosis and treatment of lymphoepithelioma-like hepatic carcinoma.
Jia J; Guo H; Liu J; Sun Q; Cao G; Zhou S; Shuai M; Gao F; Zheng S; Zhang M
J Cancer Res Clin Oncol; 2023 Sep; 149(11):8691-8697. PubMed ID: 37126105
[TBL] [Abstract][Full Text] [Related]
12. [Expression of glypican-3, hepatocyte antigen, alpha-fetoprotein, CD34 and CD10 in hepatocellular carcinoma: a clinicopathologic analysis of 375 cases].
Du JL; Wang YL; Shi HY; Guo AT; Wei LX
Zhonghua Bing Li Xue Za Zhi; 2012 May; 41(5):309-13. PubMed ID: 22883669
[TBL] [Abstract][Full Text] [Related]
13. Lymphoepithelioma-like hepatocellular carcinoma without Epstein-Barr virus infection: A case report and a review of the literature.
Wei J; Liu Q; Wang C; Yu S
Indian J Pathol Microbiol; 2015; 58(4):550-3. PubMed ID: 26549091
[TBL] [Abstract][Full Text] [Related]
14. Lymphoepithelioma-like carcinoma in liver not associated with Epstein-Barr virus: a report of 3 cases and literature review.
Zhang K; Tao C; Tao Z; Wu F; An S; Wu J; Rong W
Diagn Pathol; 2020 Sep; 15(1):115. PubMed ID: 32967689
[TBL] [Abstract][Full Text] [Related]
15. Combination of inflammatory score/liver function and AFP improves the diagnostic accuracy of HBV-related hepatocellular carcinoma.
Ding Y; Liu K; Xu Y; Zhao Q; Lou S; Xiang X; Yan L; Cao Z; Xie Q; Zhu C; Bao S; Wang H
Cancer Med; 2020 May; 9(9):3057-3069. PubMed ID: 32150664
[TBL] [Abstract][Full Text] [Related]
16. Golgi protein 73, not Glypican-3, may be a tumor marker complementary to α-Fetoprotein for hepatocellular carcinoma diagnosis.
Wang Y; Yang H; Xu H; Lu X; Sang X; Zhong S; Huang J; Mao Y
J Gastroenterol Hepatol; 2014 Mar; 29(3):597-602. PubMed ID: 24236824
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of glypican-3 in patients with HBV-associated hepatocellular carcinoma after liver transplantation.
Cui X; Li Z; Gao PJ; Gao J; Zhu JY
Hepatobiliary Pancreat Dis Int; 2015 Apr; 14(2):157-63. PubMed ID: 25865688
[TBL] [Abstract][Full Text] [Related]
18. False Positive Diagnosis of Hepatocellular Carcinoma in Liver Resection Patients.
Lee H; Yoon JH; Kim H; Yi NJ; Hong SK; Yoon KC; Kim HS; Ahn SW; Choi JY; Choi Y; Lee HW; Yi JY; Lee KB; Lee KW; Suh KS
J Korean Med Sci; 2017 Feb; 32(2):315-320. PubMed ID: 28049244
[TBL] [Abstract][Full Text] [Related]
19. Combined measurement of preoperative α-fetoprotein and des-γ-carboxy prothrombin predicts recurrence after curative resection in patients with hepatitis-B-related hepatocellular carcinoma.
Chon YE; Choi GH; Lee MH; Kim SU; Kim DY; Ahn SH; Kim KS; Choi JS; Han KH; Chon CY; Park JY
Int J Cancer; 2012 Nov; 131(10):2332-41. PubMed ID: 22362471
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic value of glypican-3 in serum and liver for primary hepatocellular carcinoma.
Liu H; Li P; Zhai Y; Qu CF; Zhang LJ; Tan YF; Li N; Ding HG
World J Gastroenterol; 2010 Sep; 16(35):4410-5. PubMed ID: 20845507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
